
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Insulinoma differential diagnosis
Introduction

Overview
Overview
Insulinoma must be differentiated from other diseases that cause features of hypoglycemia like altered mental status/confusion, profuse sweating and visual disturbances (blurring/diplopia). These are classified on the basis of laboratory findings into exogenous insulin, oral hypoglycemic agents (e.g. Sulphonylureas), Nesidioblastosis, insulin autoimmune hypoglycemia.
Differentiating insulinoma from other Diseases
Differentiating insulinoma from other Diseases
Insulinoma must be differentiated from other diseases that cause features of hypoglycemia. These are classified on the basis of laboratory findings.
Differentials for Hypoglycemia on the basis of Laboratory findings:[1]
| Diagnoses | Laboratory Findings differentiating among causes of Hypoglycemia | |||||||
|---|---|---|---|---|---|---|---|---|
| S.Glucose (mg/dL) |
C Peptide (pmol/L) | S.Insulin (μU/mL) | S.Proinsulin (pmol/L) |
S. Beta hydroxybutyrate | Glucose increase after glucagon(mg/dL) | Oral Hypoglycemic agent | Antibodies to Insulin | |
| Normal/Fasting | <55 | <200 | <3 | <5 | >2.7 | <25 | – | – |
| Exogenous Insulin | <55 | <200 | >>3 | <5 | ≤2.7 | >25 | – | – |
| Insulinoma | <55 | ≥200 | ≥3 | ≥5 | ≤2.7 | >25 | – | – |
| Nesidioblastosis | ||||||||
| Post gastric bypass hypoglycemia (PGPH) | ||||||||
| Insulin autoimmune hypoglycemia | <55 | >>200‡ | >>3 | >>5‡ | ≤2.7 | >25 | – | + |
| Oral hypoglycemic agent | <55 | ≥200 | ≥3 | ≥5 | ≤2.7 | >25 | + | – |
| IGF¤ | <55 | <200 | <3 | <5 | ≤2.7 | >25 | – | – |
|
‡ Free C-peptide and proinsulin concentrations are low | ||||||||
Differentiating hypoglycemia from other diseases that cause autonomic hyperactivity symptoms :
| Disease | Clinical Manifestation | Investigations | ||||
|---|---|---|---|---|---|---|
| Symptoms | Signs | |||||
| Palpitations | Fever | Sweating | Headache | |||
| Hypoglycemia | + | – | + | + |
|
|
| Anxiety disorders | + | – | + | + |
|
|
| Pheochromocytoma | + | + | + | + |
|
|
| Arrhythmia | + | – | – | – |
|
|
| Hyperthyroidism | + | + | + | + |
|
|
References
References
- ↑ Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER; et al. (2009). “Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline”. J Clin Endocrinol Metab. 94 (3): 709–28. doi:10.1210/jc.2008-1410. PMID 19088155.
- ↑ Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P; et al. (2002). “Biochemical diagnosis of pheochromocytoma: which test is best?”. JAMA. 287 (11): 1427–34. PMID 11903030.
- ↑ Bravo EL (1991). “Pheochromocytoma: new concepts and future trends”. Kidney Int. 40 (3): 544–56. PMID 1787652.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
